Niagen Bioscience, Inc., formerly Chromadex Corp., is a global bioscience company. It is engaged in research on nicotinamide adenine dinucleotide (NAD+), an essential coenzyme that is a key regulator of cellular metabolism and is found in every cell of the human body. The Company’s Consumer Products segment provides finished dietary supplement products that contain the Company's proprietary ingredients directly to consumers and distributors and offers NAD+ test kits exclusively to healthcare practitioners. The Ingredients segment develops and commercializes proprietary-based ingredient technologies, including food-grade Niagen and pharmaceutical-grade Niagen, and supplies these ingredients as raw materials to the manufacturers of consumer products and United States FDA-registered 503B outsourcing facilities, respectively. The Analytical Reference Standards and Services segment offers the supply of phytochemical reference standards and other research and development services.
企業コードNAGE
会社名Niagen Bioscience Inc
上場日Jun 25, 2007
最高経営責任者「CEO」Fried (Robert N)
従業員数104
証券種類Ordinary Share
決算期末Jun 25
本社所在地10900 Wilshire Blvd Suite 600
都市LOS ANGELES
証券取引所NASDAQ OMX - NASDAQ BASIC
国United States of America
郵便番号90024
電話番号13103886706
ウェブサイトhttps://www.niagenbioscience.com/
企業コードNAGE
上場日Jun 25, 2007
最高経営責任者「CEO」Fried (Robert N)
過去5年間の配当金総支払額は
0.00
米ドルである。

データなし